China FDA joins harmonization council

The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) approved China FDA as a regulatory member.

The non-profit organization's goal is to bring regulatory authorities and industry together to discuss scientific and technical aspects of drug registration, including the introduction and continued approval of drugs, prevention of clinical trial duplication and establishment of safety, efficacy and cost-effectiveness of medicines...